Oxidative stress plays an important role in atherosclerotic vascular disease, and several recent studies were focused on thioredoxin-1 (Trx-1) and its potential protective role against oxidative stress. Since human monocyte-derived macrophages (HMDM) are important cells in several inflammatory diseases including atherosclerosis, we conducted this study to evaluate the impact of extracellular recombinant human Trx-1 (rhTrx-1) on gene expression in lipopolysaccharide-activated HMDM. Our results showed that rhTrx-1 was capable of reducing interleukin (IL)-1 mRNA and protein synthesis in a dose-dependent manner. This effect was partly mediated through a reduction of NF-B activation as analyzed by transient transfection and gel shift assays. In addition, we showed that the attenuation of NF-B activity was the result of the reduction of both p50 and p65 subunit mRNA and protein synthesis on one hand and of the induction of I-B␣ mRNA and protein expression on the other hand. Moreover, inhibition of endogenous Trx-1 mRNA was also observed, suggesting a contribution to the diminution of NF-B activity since endogenous Trx-1, in contrast to the exogenous Trx-1, activates the NF-B system. Finally, H 2 O 2 -oxidized rhTrx-1 reduced IL-1 mRNA synthesis in lipopolysaccharide-activated HMDM. This result highly suggested that the rhTrx-1 used in this study could be oxidized in the culture medium and, in turn, reduced IL-1 mRNA and protein synthesis. Taken together, these data indicated a potential new mechanism through which extracellular rhTrx-1 exerts an anti-inflammatory function in HMDM.Increasing evidence indicates that oxidative stress plays an important role in atherosclerotic vascular disease (1). However, the protective mechanisms of antioxidants, including dietary antioxidants such as ascorbate (vitamin C) and ␣-tocopherol (vitamin E), have not been well defined (1). Nevertheless, recent attention was focused on thioredoxin-1 (Trx-1) 2 and its potential protective role against oxidative stress (see review (2)). Indeed, Trx-1, a 12-kDa highly conserved protein in almost all species, is the major carrier of redox potential in cells (3). Trx-1 functions by the reversible oxidization of two Trx-specific redoxactive cysteine residues (Cys-32 and Cys-35) to form a disulfide bond that, in turn, can be reduced by the action of Trx-1 reductase and NADPH.Intracellular Trx-1 exerts most of its antioxidant properties through scavenging of reactive oxygen species (4). In addition, it acts as a cofactor for several enzymes such as nucleoside diphosphate reductase (5), T7 DNA polymerase (6), and 3Јphosphoadenosylsulfate reductase (7). Moreover, mammalian Trx-1 plays an important role in the regulation of redox-sensitive transcription factors such as activator protein-1 (AP-1) and nuclear factor-B (NF-B) (8, 9) and in the regulation of glucocorticoid receptor-mediated signal transduction (9 -11).In addition to its intracellular role, intact Trx-1 and its truncated form (Trx-80) can be released by cells and exert both cytokine-like ...